New drug combo shows promise for Tough-to-Treat lymphoma
NCT ID NCT02783625
First seen May 04, 2026 · Last updated May 14, 2026 · Updated 2 times
Summary
This early-phase study tested the safety of a drug called duvelisib when given with either romidepsin or bortezomib for people with T-cell lymphoma that returned or didn't respond to prior treatment. The study involved 114 adults and aimed to find the best dose with acceptable side effects. It is not a cure, but a step toward better control of this aggressive cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Cancer Center @ Commack (Limitied protocol activities)
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Cancer Center Basking Ridge (Limited protocol activities)
Basking Ridge, New Jersey, United States
-
Memorial Sloan Kettering Monmouth (Limited protocol activities)
Middletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Nassau (Limited protocol activities)
Uniondale, New York, 11553, United States
-
Memorial Sloan Kettering Westchester (Limited protocol activities)
Harrison, New York, United States
-
Stanford University Medical Center
Stanford, California, 94305-5408, United States
-
University of Washington School of Medicine in St. Louis
St Louis, Missouri, 63110, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.